StockData
Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc. (ATNM) stock

ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3081% below fair value
$1.08−0.27 (-20.00%)

Close on Nov 18, 2026Market cap $33.96MP/E 3.0Yield –

Actinium Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Actinium Pharmaceuticals's market cap was $49.99M on Nov 11, 2026, against $43.05M a year earlier. Over the last 5 years it ranged from $26.26M to $336.75M, with a median of $113.16M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$49.99M+17.8%
2025Dec 31, 2025$42.43M+7.9%
2024Dec 31, 2024$39.31M-71.8%
2023Dec 29, 2023$139.26M-48.1%
2022Dec 30, 2022$268.51M+102.8%
2021Dec 31, 2021$132.41M+24.9%
2020Dec 31, 2020$105.97M+195.5%
2019Dec 31, 2019$35.86M-16.1%
2018Dec 31, 2018$42.76M-19.5%
2017Dec 29, 2017$53.11M+27.1%
2016Dec 30, 2016$41.78M-69.1%
2015Dec 31, 2015$135.39M-22.4%
2014Dec 31, 2014$174.46M+25.2%
2013Dec 31, 2013$139.34M+11558.1%
2012Dec 31, 2012$1.20M–

More Actinium Pharmaceuticals figures

See a number that looks wrong?